Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guilin Eight Plus One Pharmaceutical is a Chinese pharmaceutical company based in Guilin, Guangxi, specializing in the research, development, and manufacturing of both Traditional Chinese Medicine (TCM) and chemical drugs. The company operates a comprehensive business model covering the entire value chain from R&D to large-scale production and commercial distribution. Its product portfolio primarily targets cardiovascular health, digestive disorders, and respiratory conditions, with a strong emphasis on modernized TCM formulations. The company has historically been listed on China's National Equities Exchange and Quotations (NEEQ) and maintains a significant presence in the regional healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guilin Eight Plus One Pharmaceutical Research.